Shield Thera Share News (STX)

Shield Thera Information

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes

Get Live Data

5.75 -0.10 (-1.71%)

Bid:

5.70

Ask:

5.80

Spread: 0.10 (1.754%)

Market Cap: £61.50m

Last checked at -

Intraday Shield Thera Share Chart

REMOVE ADS

AIM WINNERS & LOSERS: Rockfire Resources hails Molaoi resource upgrade

Wed, 04th Sep 2024 11:06

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.

----------

AIM - WINNERS

----------

Rockfire Resources PLC, up 33% at 0.24 pence, 12-month range 0.10p-0.40p. The Greece and Australia-focused gold, base metal and critical mineral exploration company's shares jumped, after announcing a six-fold mineral resource upgrade at Molaoi. Located in Greece, Molaoi is a zinc, silver, and lead deposit. The inferred resource estimate is now 15.0 million tonnes at 7.3% zinc, 1.8% lead, and 39.5 grams per tonne of silver. This compares to a maiden resource estimate from May 2022 of 2.3 million tonnes at 11% zinc equivalent, for 250,000 tonnes of zinc equivalent. Rockfire Resources said that the new resource has "surpassed all expectations", and places Molaoi "within the top 20 undeveloped zinc resources globally in terms of tonnage, grade and zinc equivalent metal content".

----------

AIM - LOSERS

----------

Shield Therapeutics PLC, down 9.8% at 4.78p, 12-month range 1.06p-12.85p. The Newcastle, England-based commercial-stage pharmaceutical company reports a pretax loss for the six months ended June 30 of USD15.5 million, widening from USD11.8 million a year prior. This was despite an improvement in revenue, which increases to USD12.1 million from USD3.7 million. Shield said that losses were in part driven by the expansion of a US field force supporting the launch of Accrufer, its iron deficiency medication.

----------

By Holly Beveridge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com